Market Overview

Morning Market Movers

Related OMED
OncoMed Pharmaceuticals Initiates Randomized Phase 2 "ALPINE" Clinical Trial Of Tarextumab (Anti-Notch 2/3, OMP-59R5) For Pancreatic Cancer
OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
Related CELG
#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict
Fast Money Traders Share The Stocks To Buy In An Uptrend Market
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)

OncoMed Pharmaceuticals (NASDAQ: OMED) rose 67.14% to $23.40 on a deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.

Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) shares jumped 15.90% to $4.81 after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (CELG + CNAT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional